Results 11 to 20 of about 16,925 (177)
Nucleic acid testing in Colombian blood banks (2018-2024): Implementation, yield estimates and implications for safer transfusion policy. [PDF]
Abstract Background and Objectives Colombia has a population of 52.6 million inhabitants and a blood donation rate of 26 donations per 1000 inhabitants. The 84 blood banks in the country collect approximately 1 million donations annually, which are mandatorily screened for human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus ...
Bermúdez-Forero MI +1 more
europepmc +2 more sources
Potential benefits of an alternative haemoglobin deferral strategy evaluated in seven countries. [PDF]
Abstract Background and Objectives On‐site donor deferral for low haemoglobin (Hb) levels poses significant challenges for blood establishments globally, leading to material wastage and consumption of valuable staff and donor time. Traditionally, donors are deferred based on a single visit's Hb measurement, without considering previous Hb levels and ...
Meulenbeld A +16 more
europepmc +2 more sources
A procedure using low-cost reagents to prepare allogeneic platelet gel from standard platelet units. [PDF]
Abstract Background and Objectives Highly effective procedures for the preparation of allogeneic platelet gel (PG) use Ca‐gluconate and batroxobin, an expensive commercial reagent. In this preliminary study, we explored the use of the plasmin‐inhibitor, low‐cost drug tranexamic acid (TXA) in place of batroxobin, based on the literature supporting TXA ...
Mykhailova L +8 more
europepmc +2 more sources
Insulin resistance, overweight, and obesity in apheresis donors: A call to reevaluate their eligibility-A prospective cohort study. [PDF]
Abstract Background Apheresis procedures and the infusion of acid‐citrate‐dextrose induce metabolic alterations that may influence glucose metabolism. Although insulin resistance (IR), overweight, and obesity are not exclusion criteria for blood donation, their impact during apheresis procedure and on post‐donation metabolic responses remains ...
Barrientos-Galeana E +14 more
europepmc +2 more sources
Abstract In order to identify the determinants of market (donor) orientation in blood transfusion centers and services (BTCS), this study seeks to analyze whether connectedness and interpersonal trust represent a fundamental basis for interfunctional coordination that leads to market (donor) orientation.
María de la Cruz Déniz‐Déniz +3 more
wiley +1 more source
Abstract Background and Objectives Blood transfusion centres ensure the quality and safety of transfusable blood components. However, septic transfusion reactions involving environmental contaminants occur. An international survey issued by the ISBT Transfusion‐Transmitted Infectious Diseases Working Party (ISBT‐TTID‐WP) Bacterial Subgroup aimed to ...
Sandra Ramirez‐Arcos +4 more
wiley +1 more source
Abstract Background Preoperative anaemia is associated with poor outcomes in surgical patients, but the preoperative haemoglobin cut‐off that determines lower morbidity in total knee arthroplasty (TKA) and total hip arthroplasty (THA) is not well established.
Ane Abad‐Motos +23 more
wiley +1 more source
Abstract Background This study evaluated whether pathogen reduction technology (PRT) in plasma and platelets using amotosalen/ultraviolet A light (A/UVA) or in red blood cells using amustaline/glutathione (S‐303/GSH) may be used as the sole mitigation strategy preventing transfusion‐transmitted West Nile (WNV), dengue (DENV), Zika (ZIKV), and ...
Susan L. Stramer +13 more
wiley +1 more source
Introduction of 7-day amotosalen/ultraviolet A light pathogen-reduced platelets in Honduras: Impact on platelet availability in a lower middle-income country. [PDF]
Abstract Background and Objectives Honduras became the first lower middle‐income country (LMIC) to adopt amotosalen/UVA pathogen‐reduced (PR) platelet concentrates (PCs) as a national platelet safety measure in 2018. The Honduran Red Cross (HRC) produces ~70% of the national platelet supply using the platelet‐rich plasma (PRP) method.
Pedraza M +3 more
europepmc +2 more sources
Transfusión de sangre y hepatitis (Tema XIV)
Sin ...
Luigi Accatino L.
doaj +1 more source

